DG
4
-6
STI
10
-13
MOS
48
-2
ED
45
3
KMI
79
2
RCL
64
3
MRK
30
-3
LNC
28
-2
DAL
64
3
AIV
44
-3
NI
65
9
SO
55
13
COF
47
-2
ZTS
34
5
PAYX
44
6
IBM
48
-2
UHS
60
4
RIG
41
-6
ABBV
51
-4
ADI
62
5
DG
4
-6
STI
10
-13
MOS
48
-2
ED
45
3
KMI
79
2
RCL
64
3
MRK
30
-3
LNC
28
-2
DAL
64
3
AIV
44
-3
NI
65
9
SO
55
13
COF
47
-2
ZTS
34
5
PAYX
44
6
IBM
48
-2
UHS
60
4
RIG
41
-6
ABBV
51
-4
ADI
62
5
Financhill
Back

Forrester Research Vs. Janux Therapeutics Industry Stock Comparison

Sell
1

FORR
Forrester Research

Last Price:
$14.82
Seasonality Move:
-1.1%
Sell
23

JANX
Janux Therapeutics

Last Price:
$50.53
Seasonality Move:
80.32%
Sell
1
Forrester Research (FORR) is a Sell

Is Forrester Research a Buy, Sell or Hold?

  • The current Forrester Research [FORR] share price is $14.78. The Score for FORR is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • FORR is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
23
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FORR Stock Price Chart

What is Forrester Research's stock price today?

  • The Forrester Research share price today is $14.78
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FORR is experiencing buying pressure, which is a positive indicator for future bullish movement.

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $50.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

FORR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.34 Sell
Relative Strength Index (14 RSI): 33.28 Sell
Chaikin Money Flow: 65220 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.27 - 16.63) Sell
Bollinger Bands (100): (15.5 - 18.06) Sell

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 41.88 Sell
Chaikin Money Flow: -1994706 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.74 - 62.68) Sell
Bollinger Bands (100): (44.76 - 56.7) Buy

FORR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.44 Sell
20-day SMA: 15.72 Sell
50-day SMA: 16.09 Sell
200-day SMA: 17.6 Sell
8-day EMA: 15.31 Sell
20-day EMA: 15.68 Sell
50-day EMA: 16.11 Sell
200-day EMA: 18.29 Sell

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.68 Sell
20-day SMA: 56.78 Sell
50-day SMA: 54.64 Sell
200-day SMA: 47.7 Buy
8-day EMA: 54.12 Sell
20-day EMA: 55.17 Sell
50-day EMA: 54.12 Sell
200-day EMA: 45.19 Buy

Forrester Research Earnings Growth & FORR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.21 per share, and an increase next year of $0.33 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.

Forrester Research Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):